Seong Tshool Hong

This inventor holds 8 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 6 EPO patents. Top assignees: Jinis Co., Ltd., Jinis Biopharmaceuticals Co., Microbiotica Gmbh. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seong Tshool Hong. Retrieved from https://idiyas.com/inventor/seong-tshool-hong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 9)

Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 2(Granted Patents)

Location History:

Jeollabuk-do, KR (2015)
Jeonju-si, KR (2017 - 2023)

Company Filing History:

Jinis Biopharmaceuticals Co.

Republic of Korea (Management: Rural Development Administration)

6. 1 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12310995 - Gut microbes against infectious diseases and its use (2025-05-27),

2. 12290540 - Strain having ability to lower blood ammonia levels and composition comprising same for neuronal protection (2025-05-06),

3. 11752210 - Sensitizing composition using electromagnetic waves for thermal therapy of cancers, and cancer therapy using same (2023-09-12),

4. 11273188 - Strain having ability to inhibit obesity and pharmaceutical composition containing same (2022-03-15),

5. 10286004 - Targeting-enhanced anticancer nanoparticles and preparation methods of same (2019-05-14),

6. 9840716 - Resveratrol-enriched rice and the use thereof (2017-12-12),

7. 9662401 - Targeting-enhanced anticancer nanoparticles and preparation methods of same (2017-05-30),

8. 8986675 - Compositions and methods for prevention and treatment of obesity and obesity related metabolic syndrome (2015-03-24),

Title: Seong Tshool Hong: Innovator in Gut Microbiome Research

Introduction

Seong Tshool Hong is a prominent inventor based in Jeonju-si, South Korea. He has made significant contributions to the field of microbiome research, particularly in developing gut microbes that combat infectious diseases. With a total of 8 patents to his name, his work has the potential to revolutionize therapeutic approaches to various health issues.

Latest Patents

Hong's latest patents focus on the use of gut microbes to provide preventive or therapeutic effects against infectious diseases caused by pathogenic microorganisms. One of his notable inventions involves gut microbes characterized by specific strains, including species JBO3-101 and species JBR5-501. These microbes have shown the ability to render hosts resistant to infectious diseases when ingested. Another significant patent addresses microorganisms that lower blood ammonia levels, which can protect neuronal cells. This invention is particularly relevant for treating hyperammonemia and related neurological diseases.

Career Highlights

Throughout his career, Seong Tshool Hong has worked with various companies, including Jinis Co., Ltd. and Microbiotica GmbH. His innovative research has garnered attention in the scientific community, leading to advancements in the understanding of gut health and its implications for overall well-being.

Collaborations

Hong has collaborated with notable colleagues, including Hyeon Jin Kim and Hea Jong Chung. These partnerships have contributed to the success of his research and the development of his patented technologies.

Conclusion

Seong Tshool Hong's work in gut microbiome research exemplifies the intersection of innovation and health. His patents not only highlight his expertise but also pave the way for future advancements in treating infectious diseases and neurological conditions.

Profile summary based on public USPTO records.